Crizotinib in ROS1-rearranged non-small-cell lung cancer.

@article{Shaw2015CrizotinibIR,
  title={Crizotinib in ROS1-rearranged non-small-cell lung cancer.},
  author={Alice Tsang Shaw and Benjamin J. Solomon},
  journal={The New England journal of medicine},
  year={2015},
  volume={372 7},
  pages={683-4}
}
Highly Influential
This paper has highly influenced 24 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 317 extracted citations

Emerging targeted therapies in non-small cell lung cancer.

Expert review of anticancer therapy • 2016
View 3 Excerpts
Highly Influenced

Ceritinib for the treatment of late-stage (metastatic) non-small cell lung cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2015
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…